JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 1,771 articles

Articles by James Calloway

Intel Shares Retreat from 24-Year Peak as AI CPU Strategy Faces Earnings Scrutiny
Earnings

Intel Shares Retreat from 24-Year Peak as AI CPU Strategy Faces Earnings Scrutiny

Intel shares declined 3.5% to $66.08, pulling back from a 24-year high ahead of its April 23 earnings. The report is seen as a key test for whether AI spending is broadening to benefit CPU makers.

INTC NVDA AMD GOOGL TSLA APO
Boeing Showcases Chinook Drone Tech as Commercial Recovery Hinges on Q1 Earnings
Earnings

Boeing Showcases Chinook Drone Tech as Commercial Recovery Hinges on Q1 Earnings

Boeing is promoting advanced drone and autonomy features for its Chinook helicopter as investors await first-quarter earnings, with the commercial division's recovery and production targets under the microscope.

BA
7-Eleven to Shutter 645 Stores, Delays North American IPO Amid Strategic Shift
Earnings

7-Eleven to Shutter 645 Stores, Delays North American IPO Amid Strategic Shift

Seven & i Holdings plans to close 645 7-Eleven stores in North America in fiscal 2026 while opening 205 new locations, reducing its total footprint. The company has postponed its planned North American IPO to fiscal 2027 or beyond.

Psyence Biomedical Stock Surges on White House Psychedelic Research Push
Regulation

Psyence Biomedical Stock Surges on White House Psychedelic Research Push

Psyence Biomedical's stock rose sharply following a White House executive order aimed at fast-tracking research into psychedelic therapies like ibogaine, though the company's lead drug remains in mid-stage trials.

PBM
Interactive Brokers Q1 Earnings: Can Momentum Hold Amid Market Highs?
Earnings

Interactive Brokers Q1 Earnings: Can Momentum Hold Amid Market Highs?

Interactive Brokers reports first-quarter earnings Tuesday, with analysts forecasting ~60 cents per share. The broker saw strong yearly growth in trading activity and client assets in March, though monthly figures softened.

IBKR SCHW
VICI Properties Gains Ahead of Q1 Report, Investors Eye $1.5B Loan
Earnings

VICI Properties Gains Ahead of Q1 Report, Investors Eye $1.5B Loan

Shares of casino REIT VICI Properties advanced 2.15% to $29.01 Friday, outperforming major indices. Investors await first-quarter results and updated cash-flow outlook due April 29.

Grab Stock Rises Ahead of Q1 Report Amid Strategic Expansion and Buyback
Earnings

Grab Stock Rises Ahead of Q1 Report Amid Strategic Expansion and Buyback

Grab Holdings Limited's stock advanced 4.7% to $4.21 on Nasdaq ahead of its first-quarter 2026 results, with focus on its expansion into Taiwan and ongoing share buyback.

GRAB UBER
SoFi Shares Gain Ahead of Critical Q1 Report Amid Accounting Scrutiny
Earnings

SoFi Shares Gain Ahead of Critical Q1 Report Amid Accounting Scrutiny

SoFi Technologies shares climbed 2.1% Friday to $19.43 on heavy volume ahead of its April 29 earnings report. The fintech faces its first major update since short seller Muddy Waters questioned its accounting in March.

SOFI AFRM HOOD LC
Netflix Shares Slide on Subdued Q2 Outlook, Hastings Board Exit
Earnings

Netflix Shares Slide on Subdued Q2 Outlook, Hastings Board Exit

Netflix shares tumbled nearly 10% as a weak Q2 revenue and earnings projection overshadowed strong Q1 results and news of co-founder Reed Hastings' planned board departure.

NFLX
Intel Shares Surge to 24-Year Peak Ahead of Critical Earnings Report
Earnings

Intel Shares Surge to 24-Year Peak Ahead of Critical Earnings Report

Intel's stock surged to a dot-com-era high of $70.32 on Friday, fueled by AI partnerships and a major fab buyback, setting the stage for a pivotal earnings report this week.

INTC GOOGL TSLA AMD NVDA TSM APO
Alphabet's AI Spending Surge Draws Investor Scrutiny Ahead of Earnings
Earnings

Alphabet's AI Spending Surge Draws Investor Scrutiny Ahead of Earnings

Alphabet shares traded near $337 as investors await its April 29 earnings, with attention on a potential capital expenditure surge to $185 billion for 2026 and recent AI chip deals.

GOOGL META MSFT AMZN ASML TSM AVGO BLK SPY QQQ
FDA Peptide Review Sparks Rally for Hims & Hers Health
Regulation

FDA Peptide Review Sparks Rally for Hims & Hers Health

Shares of Hims & Hers Health climbed sharply after regulators signaled a review of peptide restrictions, a development analysts view as a positive shift for the company's growth strategy.

HIMS